365 related articles for article (PubMed ID: 24965406)
1. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
[TBL] [Abstract][Full Text] [Related]
3. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
J Clin Oncol; 2006 May; 24(15):2245-51. PubMed ID: 16710022
[TBL] [Abstract][Full Text] [Related]
4. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
5. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
6. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
[TBL] [Abstract][Full Text] [Related]
7. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC
Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423
[TBL] [Abstract][Full Text] [Related]
9. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
Subramanian J; Velcheti V; Gao F; Govindan R
J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
[TBL] [Abstract][Full Text] [Related]
10. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
11. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
Bryant A; Cerfolio RJ
Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study.
Pirker R; Pereira JR; Szczesna A; von Pawel J; Krzakowski M; Ramlau R; Vynnychenko I; Park K; Eberhardt WE; de Marinis F; Heeger S; Goddemeier T; O'Byrne KJ; Gatzemeier U
Lung Cancer; 2012 Aug; 77(2):376-82. PubMed ID: 22498112
[TBL] [Abstract][Full Text] [Related]
13. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
Tsao AS; Liu D; Lee JJ; Spitz M; Hong WK
Cancer; 2006 Jun; 106(11):2428-36. PubMed ID: 16634096
[TBL] [Abstract][Full Text] [Related]
14. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
J Thorac Oncol; 2011 Apr; 6(4):735-42. PubMed ID: 21258254
[TBL] [Abstract][Full Text] [Related]
16. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
17. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of smoking status in operated non-small cell lung cancer.
Sardari Nia P; Weyler J; Colpaert C; Vermeulen P; Van Marck E; Van Schil P
Lung Cancer; 2005 Mar; 47(3):351-9. PubMed ID: 15713518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
